Skip to main content

Sachdev Amit's Form 4 filing

Vertex Pharmaceuticals Inc (VRTX) · filed Feb 23, 2026

Accession no.
0000875320-26-000102
Filed
Feb 23, 2026
Trade date
Feb 19, 2026
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $27.5M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sachdev AmitCIK 0001406338Officer (EVP Chief Patient & Ext Af Off)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 19, 2026Common StockMOption exerciseAcquired+23,479$155.57+$3,652,628.0392,521Direct
Feb 19, 2026Common StockMOption exerciseAcquired+25,026$187.53+$4,693,125.78117,547Direct
Feb 19, 2026Common StockSSaleDisposed−920$463.91−$426,797.2116,627Direct
Feb 19, 2026Common StockSSaleDisposed−2,730$465.05−$1,269,586.5113,897Direct
Feb 19, 2026Common StockSSaleDisposed−1,848$465.80−$860,798.4112,049Direct
Feb 19, 2026Common StockSSaleDisposed−10,263$467.75−$4,800,518.25101,786Direct
Feb 19, 2026Common StockSSaleDisposed−19,662$468.57−$9,213,023.3482,124Direct
Feb 19, 2026Common StockSSaleDisposed−7,241$469.61−$3,400,446.0174,883Direct
Feb 19, 2026Common StockSSaleDisposed−11,712$470.54−$5,510,964.4863,171Direct
Feb 19, 2026Common StockSSaleDisposed−4,237$471.43−$1,997,448.9158,934Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 19, 2026Common StockMOption exerciseDisposed−23,479$0.00$00Direct
Feb 19, 2026Common StockMOption exerciseDisposed−25,026$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)